Jump to content

StemCells, Inc.

From Wikipedia, the free encyclopedia
StemCells, Inc.
Company typePublic
IndustryBiotechnology
Founded1 January 1992 Edit this on Wikidata
Headquarters,
United States Edit this on Wikidata
Key people
Ian Massey (CEO)
Irving L. Weissman, M.D. (Founder)
Websitewww.stemcellsinc.com

StemCells, Inc. is a public biopharmaceutical company headquartered in Newark, California, that is developing purified human neural stem cells (HuCNS-SCs) in the hopes of treating central nervous system disorders and paralysis. StemCells' HuCNS-SCs have the ability to differentiate into the three main types of cells found in the central nervous system: neurons, astrocytes and oligodendrocytes.[1][2]

They are being studied in early stage trials.[3][4]

In March 2020, Microbot Medical Inc. announced the appointment of Eyal Morag, M.D. to Chief Medical Officer.[5]

References

[edit]
  1. ^ Falco, Miriam. (Sept. 7, 2012). "A tiny step forward for spinal cord injuries."
  2. ^ Le Roux, Mariette. (March 5, 2014). "Science sees future beyond Paralympics."
  3. ^ http://www.clinicaltrials.gov/ct2/show/NCT02163876
  4. ^ "StemCells Inc says spinal injury therapy shows promise". Reuters. 2015-11-18. Retrieved 2015-12-23.
  5. ^ "Microbot Medical Appoints Eyal Morag M.D. as Chief Medical Officer". BioSpace. Retrieved 2020-03-03.
[edit]